Web Flow - Login to access your portal

Peg Bakken Named General Manager of PCI Rockford Facilities

We are pleased to announce that Peg Bakken has been promoted to the role of General Manager for our Rockford, IL based facilities, a center of excellence for commercial packaging.

The Rockford site is comprised of seven facilities that total over 1,000,000 square feet and employ over 1,500 highly trained associates, with services supporting pharmaceutical and biotech packaging, as well as medical device, and consumer healthcare products. PCI operates an extensive global supply network across North America and Europe, supporting medicines destined to over 100 countries worldwide.

Bakken joins the Rockford site having been with the company for over 16 years, most recently as the General Manager for the Woodstock, IL facility. In that capacity, Bakken was responsible for providing leadership, strategic direction and overseeing all the operational activities. Prior to her previous role at PCI, Bakken held other leadership roles in similar capacities at Catalent Pharma Solutions, Anderson Packaging, and Warner Lambert. In addition to her extensive industry background, she is experienced in Lean Six Sigma and holds a (CPIM) Certification in Production and Inventory Management.

We are very excited to have Peg in this role,” states Bill Bolding, Chief Operating Officer at PCI. “She brings a wealth of experience and truly understands the needs of our customers. Peg’s leadership style and values support our focus on creating an industry-leading customer experience.

The Rockford site has expanded site capacity recently, adding equipment for three additional bottling lines, increasing site capacity by approximately 75 million additional bottles per year. In addition, the Rockford location expanded its leading pouching capability for powders and oral solids as it experiences notable business growth. The company last week announced a considerable expansion of its Serialization capacity, effectively tripling the quantity of Serialization lines across its global supply network, including a sizable investment in the Rockford location.

Posted on Categories News

Leave a Reply

Your email address will not be published. Required fields are marked *

two × four =

Explore the PCI Process Phase by Phase

PRE-CLINICAL
PHASE I
PHASE II
PHASE III
COMMERCIAL

Swipe to explore the PCI Process

PRE CLINICAL

pre-clinical-icon
  • Formulation Development
  • Analytical development/characterisation

PHASE 1

PCI Phase 1
  • Formulation Development
  • Analytical Development
  • Drug in capsule/vial technology (Xcelodose)®
  • Phase I product manufacture
  • Tablets/Capsules
  • Blinding via over-encapsulation
  • Phase I packaging and labelling
  • Storage and distribution

PHASE 2

PCI Phase 2
  • Formulation Optimization
  • Dosage Form Process Validation
  • Analytical Testing and Stability Services
  • Phase II Product Manufacture
  • Tablets/Capsules
  • Blinding via over-encapsulation
  • Phase II packaging and labelling
  • Storage and distribution

PHASE 3

PCI Phase 3
  • Comparator Sourcing
  • Scale Up Studies
  • Phase III Product Manufacture
  • Tablets/Capsules
  • Blinding via over-encapsulation
  • Phase III packaging and labelling
  • Analytical testing and stability services
  • Storage and distribution

COMMERCIAL

PCI Commercial Phase
  • Scale up for commercial supply
  • Commercial product manufacture
  • Commercial packaging and labelling
  • Validation services
  • Analytical testing and stability services
  • Product release to market
  • Storage and distribution

PCI Points...

You told us what aspects you value as "very important" when choosing a vendor...

Why choose us...

Our global reach and localized support ensures PCI as a strategic partner remains focussed on delivering speed-to-market and the commercial success of our customers

PCI is a global company that focusses on delivering speed-to-market and the commercial success of our customers

Why choose us...